|
1 | | -Prostate-MRI_Lesion_Detection, v3.0 (Release date: September 17, 2024) |
2 | | -DEFINITIONS: AUTHOR(S) NVIDIA Corp. and National Cancer Institute, NIH |
3 | | -
|
4 | | -PROVIDER: the National Cancer Institute (NCI), a participating institute of the |
5 | | -National Institutes of Health (NIH), and an agency of the United States Government. |
6 | | -
|
7 | | -SOFTWARE: the machine readable, binary, object code form, |
8 | | -and the related documentation for the modules of the Prostate-MRI_Lesion_Detection, v2.0 |
9 | | -software package, which is a collection of operators which accept (T2, ADC, and High |
10 | | -b-value DICOM images) and produce prostate organ and lesion segmentation files |
11 | | -
|
12 | | -RECIPIENT: the party that downloads the software. |
13 | | -
|
14 | | -By downloading or otherwise receiving the SOFTWARE, RECIPIENT may |
15 | | -use and/or redistribute the SOFTWARE, with or without modification, |
16 | | -subject to RECIPIENT’s agreement to the following terms: |
17 | | -
|
18 | | -1. THE SOFTWARE SHALL NOT BE USED IN THE TREATMENT OR DIAGNOSIS |
19 | | -OF HUMAN SUBJECTS. RECIPIENT is responsible for |
20 | | -compliance with all laws and regulations applicable to the use |
21 | | -of the SOFTWARE. |
22 | | -
|
23 | | -2. THE SOFTWARE is distributed for NON-COMMERCIAL RESEARCH PURPOSES ONLY. RECIPIENT is |
24 | | -responsible for appropriate-use compliance. |
25 | | -
|
26 | | -3. RECIPIENT agrees to acknowledge PROVIDER’s contribution and |
27 | | -the name of the author of the SOFTWARE in all written publications |
28 | | -containing any data or information regarding or resulting from use |
29 | | -of the SOFTWARE. |
30 | | -
|
31 | | -4. THE SOFTWARE IS PROVIDED "AS IS" AND ANY EXPRESS OR IMPLIED |
32 | | -WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES |
33 | | -OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT |
34 | | -ARE DISCLAIMED. IN NO EVENT SHALL THE PROVIDER OR THE INDIVIDUAL DEVELOPERS |
35 | | -BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR |
36 | | -CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF |
37 | | -SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS |
38 | | -INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN |
39 | | -CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) |
40 | | -ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF |
41 | | -THE POSSIBILITY OF SUCH DAMAGE. |
42 | | -
|
43 | | -5. RECIPIENT agrees not to use any trademarks, service marks, trade names, |
44 | | -logos or product names of NVIDIA, NCI or NIH to endorse or promote products derived |
45 | | -from the SOFTWARE without specific, prior and written permission. |
46 | | -
|
47 | | -6. For sake of clarity, and not by way of limitation, RECIPIENT may add its |
48 | | -own copyright statement to its modifications or derivative works of the SOFTWARE |
49 | | -and may provide additional or different license terms and conditions in its |
50 | | -sublicenses of modifications or derivative works of the SOFTWARE provided that |
51 | | -RECIPIENT’s use, reproduction, and distribution of the SOFTWARE otherwise complies |
52 | | -with the conditions stated in this Agreement. Whenever Recipient distributes or |
53 | | -redistributes the SOFTWARE, a copy of this Agreement must be included with |
54 | | -each copy of the SOFTWARE. |
| 1 | +Prostate-MRI_Lesion_Detection, v3.0 (Release date: September 17, 2024) |
| 2 | +DEFINITIONS: AUTHOR(S) NVIDIA Corp. and National Cancer Institute, NIH |
| 3 | + |
| 4 | +PROVIDER: the National Cancer Institute (NCI), a participating institute of the |
| 5 | +National Institutes of Health (NIH), and an agency of the United States Government. |
| 6 | + |
| 7 | +SOFTWARE: the machine readable, binary, object code form, |
| 8 | +and the related documentation for the modules of the Prostate-MRI_Lesion_Detection, v2.0 |
| 9 | +software package, which is a collection of operators which accept (T2, ADC, and High |
| 10 | +b-value DICOM images) and produce prostate organ and lesion segmentation files |
| 11 | + |
| 12 | +RECIPIENT: the party that downloads the software. |
| 13 | + |
| 14 | +By downloading or otherwise receiving the SOFTWARE, RECIPIENT may |
| 15 | +use and/or redistribute the SOFTWARE, with or without modification, |
| 16 | +subject to RECIPIENT’s agreement to the following terms: |
| 17 | + |
| 18 | +1. THE SOFTWARE SHALL NOT BE USED IN THE TREATMENT OR DIAGNOSIS |
| 19 | +OF HUMAN SUBJECTS. RECIPIENT is responsible for |
| 20 | +compliance with all laws and regulations applicable to the use |
| 21 | +of the SOFTWARE. |
| 22 | + |
| 23 | +2. THE SOFTWARE is distributed for NON-COMMERCIAL RESEARCH PURPOSES ONLY. RECIPIENT is |
| 24 | +responsible for appropriate-use compliance. |
| 25 | + |
| 26 | +3. RECIPIENT agrees to acknowledge PROVIDER’s contribution and |
| 27 | +the name of the author of the SOFTWARE in all written publications |
| 28 | +containing any data or information regarding or resulting from use |
| 29 | +of the SOFTWARE. |
| 30 | + |
| 31 | +4. THE SOFTWARE IS PROVIDED "AS IS" AND ANY EXPRESS OR IMPLIED |
| 32 | +WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES |
| 33 | +OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT |
| 34 | +ARE DISCLAIMED. IN NO EVENT SHALL THE PROVIDER OR THE INDIVIDUAL DEVELOPERS |
| 35 | +BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR |
| 36 | +CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF |
| 37 | +SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS |
| 38 | +INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN |
| 39 | +CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) |
| 40 | +ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF |
| 41 | +THE POSSIBILITY OF SUCH DAMAGE. |
| 42 | + |
| 43 | +5. RECIPIENT agrees not to use any trademarks, service marks, trade names, |
| 44 | +logos or product names of NVIDIA, NCI or NIH to endorse or promote products derived |
| 45 | +from the SOFTWARE without specific, prior and written permission. |
| 46 | + |
| 47 | +6. For sake of clarity, and not by way of limitation, RECIPIENT may add its |
| 48 | +own copyright statement to its modifications or derivative works of the SOFTWARE |
| 49 | +and may provide additional or different license terms and conditions in its |
| 50 | +sublicenses of modifications or derivative works of the SOFTWARE provided that |
| 51 | +RECIPIENT’s use, reproduction, and distribution of the SOFTWARE otherwise complies |
| 52 | +with the conditions stated in this Agreement. Whenever Recipient distributes or |
| 53 | +redistributes the SOFTWARE, a copy of this Agreement must be included with |
| 54 | +each copy of the SOFTWARE. |
0 commit comments